Tobiflamin eye drops 5 ml — Made in Ukraine — Free Delivery

The preparation "Tobiflamin" is used for inflammation of the eyes in patients sensitive to steroids, in whom the use of corticosteroids is indicated and there is a superficial bacterial infection or the risk of developing a bacterial infection of the eye. These inflammations can occur after surgery or can be caused by an infection, a foreign body in the eye, or an eye injury.

1 ml of suspension contains (active ingredients):

tobramycin - 3.0 mg;

dexamethasone - 1.0 mg;

Excipients: benzalkonium chloride, disodium edetate, sodium chloride, sodium sulfate anhydrous, tyloxapol, hydroxyethyl cellulose, sulfuric acid and / or sodium hydroxide, water for injection.

hypersensitivity to active ingredients or to any component of the preparation;

keratitis caused by the herpes simplex virus;

vaccinia, chickenpox and other viral infections of the cornea and conjunctiva;

fungal diseases of the structures of the eye or untreated parasitic infections of the eye;

mycobacterial infections of the eye.

For ophthalmic use.

Use for adults, including elderly patients, and children from 12 to 18 years old

Instill one or two drops into the conjunctival sac (s) every 4-6 hours. During the first 24 to 48 hours, the dose can be increased to one or two drops every 2 hours. The frequency of use of the preparation should be gradually reduced with the improvement of clinical signs.

You should be careful not to stop therapy prematurely.

In severe diseases, instill one or two drops every hour until the inflammation becomes controlled, and gradually reduce the frequency of use to one or two drops every 2 hours for 3 days; after that, instill 1-2 drops every 4 hours for 5-8 days and at the end - 1-2 drops every day for the last 5-8 days, if necessary.

After cataract surgery, the dose is one drop 4 times a day, starting from the day of the operation and continuing for 24 days. Treatment can be started the day before the operation, one drop 4 times a day, continuing to instill one drop after the operation, and then 4 times a day for 23 days. If necessary, the frequency of use of the preparation can be increased to one drop every 2 hours during the first two days of therapy.

It is recommended to constantly monitor intraocular pressure.

It is recommended to press on the nasolacrimal opening and carefully close the eyelids after instillation. This reduces the systemic absorption of the preparation injected into the eye, which reduces the likelihood of systemic side effects.

The data obtained confirm the safety and efficacy of using the preparation in children from 1 year old, who have been using the preparation for 7 days for the treatment of superficial inflammation of the eye of bacterial origin.

It can be used for children who need to undergo surgery to remove cataracts.

Shake well before use.

To prevent contamination of the edge of the dropper and the contents of the bottle, care must be taken not to touch the eyelids, adjacent areas and other surfaces with the edge of the dropper bottle.

Store bottle upright.

Pregnant

It is not recommended to use the preparation "Tobiflamin" during pregnancy.

Since many preparations pass into breast milk, you should consider temporarily stopping breastfeeding while using the preparation.

Drivers

This preparation does not affect or has little effect on the ability to drive vehicles or other mechanisms. Temporary blurred vision or other visual impairments may affect the ability to drive vehicles or other mechanisms. If blurred vision occurs during instillation, the patient must wait until vision clears up before driving vehicles or other mechanisms.

Given the characteristics of this topical medicinal product, no toxic effect is expected when it is used in ophthalmology at the recommended doses, or if the contents of the vial are accidentally swallowed. Possible clinical signs and symptoms of preparation overdose (punctate keratitis, erythema, increased lacrimation, edema and itching of the eyelids) may be similar to side effects that have been observed in some patients.

In case of an overdose of the preparation "Tobiflamin" when applied topically, wash the excess of the preparation from the eye (s) with warm water.

The most common adverse reactions, which occurred in less than 1% of patients, were eye pain, increased intraocular pressure, eye irritation and itchy eyes.